Taranto, Italy Clinical Trials

A listing of Taranto, Italy clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

The experimental treatment consists in the application of a therapeutic strategy with post Transplant High-Dose Cyclophosphamide as GvHD Prophylaxis in Patients Receiving 1-Antigen/Allele HLA Mismatched (7/8 matched) Unrelated Hemopoietic Stem Cell Transplantation for Myeloid Malignancies.

Ospedale Moscati
 (2.9 away) Contact site
  • 0 views
  • 26 Mar, 2021
  • +32 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

hormone therapy
erbb2
trastuzumab
invasive breast cancer
HER2
Ospedale S.G. Moscati
 (5.7 away) Contact site
  • 0 views
  • 17 Jun, 2021
  • +503 other locations
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

The purpose of the study is to compare the efficacy and safety of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis who have suboptimal response while receiving ruxolitinib monotherapy.

Piazza Giulo Cesare 11
 (47.9 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +159 other locations
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.

Universita Di Napoli Federico Ii
 (161.5 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +134 other locations
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

The present study aims at analyzing the response to treatment of adult patients homogeneously treated with supportive care, chemotherapy and blinatumomab.

lymphoid leukemia
cancer
blinatumomab
corticosteroids
Divisione di Ematologia Ospedale A. Perrino
 (38.1 away) Contact site
  • 16 views
  • 24 Jan, 2021
  • +71 other locations
Pentaglobin in CRE and PA Neutropenic Infections

To demonstrate that the early addition of Pentaglobin to the best available antimicrobial therapy is able to reduce mortality and improve survival in neutropenic febrile acute leukemia or allo- Hematopoietic stem cell transplantation (HSCT) patients colonized by carbapenem-resistant Enterobacteriaceae or by any Pseudomonas aeruginosa.

Ospedale Moscati
 (2.9 away) Contact site
  • 0 views
  • 25 Mar, 2021
  • +20 other locations
Validation of the Italian Version of the PRO-CTCAE

The aim of this study is to complete the validation process by testing the remaining two psychometric properties (validity and responsiveness) of the Italian version of the PRO-CTCAE in a large group of patients. In particular, for the first time this study will validate the tool for individual types of …

primary cancer
U.O.C. Oncologia Medica - Ospedale Senatore Antonio Perrino
 (38.1 away) Contact site
  • 0 views
  • 12 Mar, 2021
  • +24 other locations
Prospective Survey of CMV Herpesviruses Infections and Diseases in Allo-HSCT

Prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, Italian with objective to describe the incidence of CMV infections and diseases in adult and pediatric patients undergoing allo-HSCT during the first 6 months from transplant. This study will evaluate approximately 1500 subjects (with competitive enrolment) from GITMO investigational centers.

Ospedale Moscati
 (2.9 away) Contact site
  • 0 views
  • 24 Mar, 2021
  • +48 other locations
A Prospective Observational Study for Evaluating CGVHD

Prospective, observational, multicentre, spontaneous, non-interventional study This study will evaluate all consecutive patients who develop chronic graft-versus-host disease, reported by the Italian GITMO centers according to a standardized Web platform for real-time, onsite data collection. The platform for data collection will be based on a software prototype developed by the …

Policlinico di Bari-Ematologia con trapianti
 (49.0 away) Contact site
  • 6 views
  • 27 Mar, 2021
  • +53 other locations
COVID19-hematological Malignancies: the Italian Hematology Alliance

This is a retrospective/prospective, cohort, non-interventional observational study. This means that all patients with documented COVID and HM diagnosed between February 2020 and study initiation will compose the retrospective part, while those diagnosed after study approval will enter prospective part. The total duration of the study will be 12 months. …

myelodysplastic syndromes
myeloproliferative disorder
lymphoma
leukemia
cancer
SC Ematologia, Policlinico Bari
 (49.0 away) Contact site
  • 0 views
  • 26 May, 2021
  • +77 other locations